MedPath

A Research Study to Compare a New Weekly Insulin, Insulin Icodec Used With DoseGuide App, and Daily Insulins in People With Type 2 Diabetes Who Have Not Used Insulin Before

Phase 3
Completed
Conditions
Diabetes Mellitus, Type 2
Interventions
Drug: Insulin Glargine 100U/mL
Drug: Insulin Glargine 300U/mL
Registration Number
NCT04760626
Lead Sponsor
Novo Nordisk A/S
Brief Summary

This study compares insulin icodec to different daily insulins in people with type 2 diabetes.

The study will look at how well insulin icodec taken once weekly controls blood sugar compared to the insulins taken once daily. Participants will either get insulin icodec, that participants will have to inject once a week on the same day of the week, or a marketed insulin, that participants will have to inject once a day. Which treatment participants get is decided at random.

The insulin is injected with a needle in a skin fold in the thigh, upper arm or stomach.

Participants will measure their blood sugar every day. Participants will get a study phone to record safety data in the electronic diary (eDiary). If participants get a daily insulin they will record their insulin doses in the eDiary. If Participants get weekly insulin icodec, participants study phone will also have the DoseGuide App. The DoseGuide App gives dose recommendations based on their blood sugar and previous doses. Participants will record their insulin doses in the DoseGuide App.

The study will last for about 1 year and 2 months. Participants will have 8 planned clinic visits with the study doctor. More visits will be planned to meet individual needs. At 6 clinic visits participants will have blood samples taken.

Women cannot take part if pregnant, breast-feeding or plan to become pregnant during the study period.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1085
Inclusion Criteria
  • Informed consent obtained before any trial-related activities. Trial-related activities are any procedures that are carried out as part of the trial, including activities to determine suitability for the trial.
  • Male or female.
  • Age above or equal to 18 years at the time of signing informed consent.
  • Diagnosed with T2D greater than or equal to 180 days prior to the day of screening.
  • HbA1c above 7.0% (53 mmol/mol) as measured by central lab.
  • Insulin naïve. However, short term insulin treatment for a maximum of 14 days prior to the day of screening is allowed, as is prior insulin treatment for gestational diabetes.
  • Stable daily dose(s) greater than or equal to 90 days prior to the day of screening of any of the following antidiabetic drug(s) or combination regimen(s): a .Any metformin formulations greater than or equal to 1500 mg or maximum tolerated or effective dose. b .Any metformin combination formulations greater than or equal to 1500 mg or maximum tolerated or effective dose. c. Any of the following non-insulin antidiabetic drug classes including combinations (greater than or equal to half of the maximum approved dose according to local label or maximum tolerated or effective dose):i). Sulfonylureas ii). Meglitinides (glinides) iii). DPP-4 inhibitors iv. SGLT2 inhibitors v). Thiazolidinediones vi). Alpha-glucosidase inhibitors vii). Oral combination products (for the allowed individual Oral Antidiabetic Drugs (OADs)) viii). Oral or injectable GLP-1-receptor agonists.
  • Intensification with insulin is indicated to achieve glycaemic target (4.4-7.2 mmol/L, 80-130 mg/dL) at the discretion of the treating investigator.
Exclusion Criteria
  • Known or suspected hypersensitivity to trial product(s) or related products.
  • Previous participation in this trial. Participation is defined as signed informed consent.
  • Female who is pregnant, breast-feeding or intends to become pregnant or is of child-bearing potential and not using an adequate contraceptive method (adequate contraceptive measures as required by local regulation or practice).
  • Participation in any clinical trial of an approved or non-approved investigational medicinal product within 30 days before screening. (Simultaneous participation in a trial with the primary objective of evaluating an approved or non-approved investigational medicinal product for prevention or treatment of COVID-19 disease or postinfectious conditions is allowed if the last dose of the investigational medicinal product has been received more than 30 days before screening)
  • Any disorder which in the investigator's opinion might jeopardise subject's safety.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Once daily basal insulin analoguesInsulin Glargine 100U/mLParticipants randomised to basal insulin analogue injections once daily
Once daily basal insulin analoguesInsulin Glargine 300U/mLParticipants randomised to basal insulin analogue injections once daily
Insulin icodec with DoseGuideInsulin icodecParticipants randomised to insulin icodec will use insulin icodec with the DoseGuide App to guide their titration.
Once daily basal insulin analoguesInsulin DegludecParticipants randomised to basal insulin analogue injections once daily
Primary Outcome Measures
NameTimeMethod
Change in HbA1c (glycated haemoglobin)From baseline week 0 (V2) to week 52 (V6)

%-point

Secondary Outcome Measures
NameTimeMethod
Number of severe hypoglycaemic episodes (level 3)From baseline week 0 (V2) to week 57 (V8)

Number of episodes

Time from baseline to treatment discontinuation or intensificationFrom baseline week 0 (V2) to week 52 (V6)

Days

Change in DTSQs (Diabetes Treatment Satisfaction Questionnaire) in total treatment satisfactionFrom baseline week 0 (V2) to week 52 (V6)

Score of 0-36. 6 items scored on a scale of 0 to 6. The higher the score the greater the satisfaction with treatment.

Trim-D (Treatment Related Impact Measure for Diabetes) compliance domainAt end of treatment week 52 (V6)

Score of 4-20. 4 items scored on a scale of 1 to 5 Transformed to a 0-100 scale with higher scores corresponding to better compliance.

Number of clinically significant hypoglycaemic episodes (level 2) (below 3.0 mmol/L (54 mg/dL), confirmed by BG meter)From baseline week 0 (V2) to week 57 (V8)

Number of episodes

Number of clinically significant hypoglycaemic episodes (level 2) (below 3.0 mmol/L (54 mg/dL), confirmed by BG meter) or severe hypoglycaemic episodes (level 3)From baseline week 0 (V2) to week 57 (V8)

Number of episodes

Trial Locations

Locations (178)

Cedar-Crosse Research Center

🇺🇸

Chicago, Illinois, United States

Iatriko Psychicou Private Clinic

🇬🇷

Athens, Greece

Korgiallenio - Benakio Hospital (Red Cross Hosp.)

🇬🇷

Athens, Greece

"Laiko" General Hospital of Athens

🇬🇷

Athens, Greece

Iatriko Athinon 'Palaiou Falirou'

🇬🇷

Athens, Greece

Univ Gen Hospital Larisa, Endocrinology & Metabolic Disease

🇬🇷

Larissa, Greece

General Hospital of Thessaloniki 'G. Gennimatas

🇬🇷

Thessaloniki, Greece

AHEPA General University Hospital

🇬🇷

Thessaloniki, Greece

"Ippokrateio" General Hosp Thessaloniki, A' Internal Med

🇬🇷

Thessaloniki, Greece

EUROMEDICA Gen Clinic The/ki, Endocrin,Metabolism,Diabetes

🇬🇷

Thessaloniki, Greece

"Thermi" Private Hosital

🇬🇷

Thessaloniki, Greece

Oddzial Chorób - Wewn.

🇵🇱

Poznan, Poland

Poradnia dla Chorych na Cukrzycę

🇵🇱

Zabrze, Poland

New Venture Medical Research

🇺🇸

Wadsworth, Ohio, United States

First Valley Medical Group

🇺🇸

Lancaster, California, United States

San Diego Family Care

🇺🇸

San Diego, California, United States

Holston Medical Group

🇺🇸

Kingsport, Tennessee, United States

Southgate Medical Group, LLP

🇺🇸

West Seneca, New York, United States

Valley Clinical Trials, Inc.

🇺🇸

Northridge, California, United States

MedStar Community Clin Res Ctr

🇺🇸

Hyattsville, Maryland, United States

Jefferson City Medical Group, PC

🇺🇸

Jefferson City, Missouri, United States

Torrance Clin Res Inst, Inc.

🇺🇸

Lomita, California, United States

Cotton O'Neil Clin Research Ctr

🇺🇸

Topeka, Kansas, United States

San Fernando Valley Hlth Inst

🇺🇸

West Hills, California, United States

Suncoast Clinical Research, Inc.

🇺🇸

Palm Harbor, Florida, United States

Mid Hudson Medical Research, PLLC

🇺🇸

New Windsor, New York, United States

American Clinical Trials

🇺🇸

Buena Park, California, United States

Elite Clinical Trials

🇺🇸

Blackfoot, Idaho, United States

Diab & Endo Assoc of Stark Co

🇺🇸

Canton, Ohio, United States

Palm Research Center Inc-Vegas

🇺🇸

Las Vegas, Nevada, United States

Palm Harbor Medical Associates

🇺🇸

Palm Harbor, Florida, United States

Endo and Metab Consultants

🇺🇸

Rockville, Maryland, United States

Est Cst Inst for Rsrch,Jksnvil

🇺🇸

Jacksonville, Florida, United States

Valley Research

🇺🇸

Fresno, California, United States

Arcturus Healthcare, PLC.

🇺🇸

Troy, Michigan, United States

AM Diabetes And Endocrinology Center

🇺🇸

Bartlett, Tennessee, United States

Velocity Clinical Res-Dallas

🇺🇸

Dallas, Texas, United States

UT Southwestern Med Cntr

🇺🇸

Dallas, Texas, United States

Chattanooga Medical Research, LLC

🇺🇸

Chattanooga, Tennessee, United States

Albuquerque Clin Trials, Inc.

🇺🇸

Albuquerque, New Mexico, United States

Juno Research, LLC

🇺🇸

Houston, Texas, United States

Endo Res Solutions, Inc

🇺🇸

Roswell, Georgia, United States

Protenium Clinical Research

🇺🇸

Hurst, Texas, United States

Northern Pines Hlth Ctr, PC

🇺🇸

Buckley, Michigan, United States

Providence Health Partners Ctr

🇺🇸

Dayton, Ohio, United States

TPMG Clinical Research

🇺🇸

Newport News, Virginia, United States

Endocrine Associates of Long Island, PC

🇺🇸

Smithtown, New York, United States

Rivergrove Medical Clinic

🇨🇦

Winnipeg, Manitoba, Canada

Andres Garcia-Zuniga, MD, P.A

🇺🇸

Laredo, Texas, United States

LMC Endo Ctr (Etobicoke) Ltd

🇨🇦

Etobicoke, Ontario, Canada

Institut für Diabetesforschung GmbH Münster - Dr. med. Rose

🇩🇪

Münster, Germany

Amarillo Med Spec LLP

🇺🇸

Amarillo, Texas, United States

Chrysalis Clinical Research

🇺🇸

Saint George, Utah, United States

LMC Diabetes & Endocrinology (Barrie)

🇨🇦

Barrie, Ontario, Canada

LMC (Thornhill)

🇨🇦

Concord, Ontario, Canada

Univ Diab & Endo Consultants

🇺🇸

Chattanooga, Tennessee, United States

Texas Diab & Endo, P.A.

🇺🇸

Round Rock, Texas, United States

PrimeCare Medical Group

🇺🇸

Houston, Texas, United States

HealthStar Physicians PC

🇺🇸

Morristown, Tennessee, United States

Zentrum für klinische Forschung, Dr. med. Lüdemann

🇩🇪

Falkensee, Germany

Clinical Inv Spec, Inc.Kenosha

🇺🇸

Kenosha, Wisconsin, United States

Centricity Research LMC

🇨🇦

Brampton, Ontario, Canada

Medical Colleagues-Texas LLP

🇺🇸

Katy, Texas, United States

Fmc Science, Llc

🇺🇸

Lampasas, Texas, United States

The Bailey Clinic

🇨🇦

Red Deer, Alberta, Canada

Dr. Anil K Gupta Medicine Professional Corporation

🇨🇦

Toronto, Ontario, Canada

Western Univ. Cnt for Studies in Fam Med

🇨🇦

London, Ontario, Canada

LMC Research Inc. Ottawa

🇨🇦

Nepean, Ontario, Canada

Winnipeg Clinic

🇨🇦

Winnipeg, Manitoba, Canada

ViaCar Recherche Clinique Inc

🇨🇦

Brossard, Quebec, Canada

Diex Recherche Quebec Inc.

🇨🇦

Quebec, Canada

LMC Clin Rsrch Inc. (Montreal)

🇨🇦

Saint-Laurent, Quebec, Canada

InnoDiab Forschung GmbH

🇩🇪

Essen, Germany

Belinus Bt.

🇭🇺

Debrecen, Hajdu-Bihar Varmegye, Hungary

'G. Gennimatas' General Hospital of Athens

🇬🇷

Athens, Greece

Diex Recherche Victoriaville

🇨🇦

Victoriaville, Quebec, Canada

Recherche Clinique Sigma inc

🇨🇦

Quebec, Canada

Wendisch/Dahl Hamburg

🇩🇪

Hamburg, Germany

Óbudai Egészségügyi Centrum

🇭🇺

Budapest, Hungary

Szegedi Tudomanyegyetem St Györgyi Albert Klinikai Központ

🇭🇺

Szeged, Hungary

ClinDiab Egészségügyi Szolgáltató és Kereskedelmi Kft.

🇭🇺

Budapest, Hungary

MedicalCenter am Clemenshospital

🇩🇪

Münster, Germany

Diabetespraxis Mergentheim

🇩🇪

Bad Mergentheim, Germany

Milek, Hohenmölsen

🇩🇪

Hohenmölsen, Germany

Baskent Universitesi Adana

🇹🇷

Adana, Turkey

Ankara Universitesi Ibni Sina Hastanesi

🇹🇷

Ankara, Turkey

Bieler, Riesa

🇩🇪

Riesa, Germany

Kaposi Mór Oktató Kórház

🇭🇺

Kaposvár, Hungary

Medizinisches Versorgungszentrum Am Bahnhof Spandau GbR

🇩🇪

Berlin, Germany

Uno Medical Trials Eü. Szolgáltató és Kereskedelmi Kft.

🇭🇺

Budapest, Hungary

Centrum Medyczne Pratia Katowice

🇵🇱

Katowice, Poland

Katedra i Klinika Chorob Wewnetrznych AM w Lublinie

🇵🇱

Lublin, Poland

Gaziantep Universitesi Tip Fakultesi Hastanesi

🇹🇷

Gaziantep, Turkey

MED-TIMA Kft.

🇭🇺

Budapest, Hungary

Centrum Medyczne Pratia Gdynia

🇵🇱

Gdynia, Pomorskie, Poland

Pro Salus Centrum Medyczne

🇵🇱

Lodz, Poland

Lubelskie Centrum Diagnostyczne Tomasz Blicharski

🇵🇱

Swidnik, Poland

Hatay Mustafa Kemal Universitesi Saglik Uygulama ve Arastirm

🇹🇷

Hatay, Turkey

Markusovszky Egyetemi Oktatókórház

🇭🇺

Szombathely, Hungary

Szőcs Depot Egészségügyi Szolgáltató Kft.

🇭🇺

Budapest, Hungary

MH Egészségügyi Központ

🇭🇺

Budapest, Hungary

NZOZ Gdanska Poradnia Cukrzycowa Sp.z o.o.

🇵🇱

Gdansk, Poland

Gabinet Lekarski Malgorzata Saryusz-Wolska

🇵🇱

Lodz, Poland

Manati Ctr For Clin Research

🇵🇷

Manati, Puerto Rico

Seyrantepe Hamidiye Etfal Egitim ve Arastirma Hastanesi

🇹🇷

Istanbul, Turkey

T.C. S.B. Ist Il SagMud Pendik Egitim ve Arastirma Hastanesi

🇹🇷

Istanbul, Turkey

Clinical Trials of Texas, LLC

🇺🇸

San Antonio, Texas, United States

NE Clin Res of San Antonio

🇺🇸

San Antonio, Texas, United States

G.A. Research Associates Ltd.

🇨🇦

Moncton, New Brunswick, Canada

Eastern Health Authority

🇨🇦

St. Johns, Newfoundland and Labrador, Canada

Commonwealth Medical Clinic

🇨🇦

Mount Pearl, Newfoundland and Labrador, Canada

Dr. M.B. Jones Inc

🇨🇦

Victoria, British Columbia, Canada

Selye János Kórház és Rendelőintézet

🇭🇺

Komárom, Komárom-Esztergom, Hungary

Univ of Alabama Birmingham

🇺🇸

Birmingham, Alabama, United States

Kanuni Sultan Suleyman Egitim ve Arastirma Hastanesi

🇹🇷

Istanbul, Turkey

Istanbul Universitesi Istanbul Tip Fakultesi - Endokrinoloji

🇹🇷

Istanbul, Turkey

Haydarpasa Numune Hastanesi

🇹🇷

Istanbul, Turkey

Medical Trust Clinics, Inc.

🇨🇦

Courtice, Ontario, Canada

Wharton Med Clin Trials

🇨🇦

Hamilton, Ontario, Canada

Hamilton Med Res Group

🇨🇦

Hamilton, Ontario, Canada

Milestone Research

🇨🇦

London, Ontario, Canada

LMC Oakville

🇨🇦

Oakville, Ontario, Canada

Bluewater Clin Res Group,Inc

🇨🇦

Sarnia, Ontario, Canada

Winterberry Family Medicine

🇨🇦

Stoney Creek, Ontario, Canada

LMC Endo Centres Ltd.(Bayview)

🇨🇦

Toronto, Ontario, Canada

Ecogene-21

🇨🇦

Chicoutimi, Quebec, Canada

Manna Research Mirabel

🇨🇦

Mirabel, Quebec, Canada

Ctr de rech Clin de Laval

🇨🇦

Laval, Quebec, Canada

Applied Med Inf Res

🇨🇦

Montreal, Quebec, Canada

Diex Recherche Joliette

🇨🇦

Saint-Charles-Borromee, Quebec, Canada

Ctr Méd. et pro d l'Ost d port

🇨🇦

St-Marc-des-Carrières, Quebec, Canada

Centre de Recherche Saint-Louis

🇨🇦

Quebec, Canada

Lakeview Clinical Research, LLC

🇺🇸

Guntersville, Alabama, United States

RED-Institut für medizinische Forschung und Fortbildung GmbH

🇩🇪

Oldenburg in Holstein, Germany

Praxis Dr. med. Wenzl-Bauer

🇩🇪

Rehlingen-Siersburg, Germany

Zentrum für klinische Studien Allgäu Oberschwaben

🇩🇪

Wangen, Germany

Methodist Physicians Clin

🇺🇸

Omaha, Nebraska, United States

Univ of Nebraska Medical CTR

🇺🇸

Omaha, Nebraska, United States

Zala Megyei Szent Rafael Kórház

🇭🇺

Zalaegerszeg, Hungary

Simcare Medical Research, LLC

🇺🇸

Sugar Land, Texas, United States

Scripps Whittier Diabetes Inst

🇺🇸

La Jolla, California, United States

Adult Medicine of Lake County, Inc.

🇺🇸

Mount Dora, Florida, United States

Encompass Clinical Research_Spring Valley

🇺🇸

Spring Valley, California, United States

Suncoast Clin Res Port Richey

🇺🇸

New Port Richey, Florida, United States

Southern New Hampshire Diabetes and Endocrinology

🇺🇸

Nashua, New Hampshire, United States

Albany Medical College - Endo

🇺🇸

Albany, New York, United States

Physicians East Endocrinology

🇺🇸

Greenville, North Carolina, United States

Plains Clinical Research Center, LLC_Fargo

🇺🇸

Fargo, North Dakota, United States

Accellacare

🇺🇸

Wilmington, North Carolina, United States

The Diabetes Center, LLC

🇺🇸

Murrells Inlet, South Carolina, United States

Hillcrest Clinical Research

🇺🇸

Simpsonville, South Carolina, United States

LMC Clin Res Inc. Calgary

🇨🇦

Calgary, Alberta, Canada

Erlinger

🇩🇪

Stuttgart, Germany

Zentrum für klinische Studien Alexander Segner

🇩🇪

Saint Ingbert-Oberwürzbach, Germany

"Ippokrateio" G.H. of Thessaloniki

🇬🇷

Thessaloniki, Greece

General Hospital of Thessaloniki "G.Papanikolaou"

🇬🇷

Thessaloniki, Greece

Szent Margit Kórház

🇭🇺

Budapest, Hungary

Velocity Nova Sp. z o.o.

🇵🇱

Staszow, Poland

T.C. Saglık Bakanlıgı Adana Sehir Egitim ve Arastirma Hastan

🇹🇷

Adana, Turkey

T.C SB Goztepe Prof. Dr. Suleyman Yalcin City Hospital

🇹🇷

Istanbul, Turkey

Umraniye Egitim ve Arastirma Hastanesi

🇹🇷

Istanbul, Turkey

Dokuz Eylul University Medical Faculty

🇹🇷

Izmir, Turkey

Erciyes Universitesi Tip Fakultesi

🇹🇷

Kayseri, Turkey

Advanced Investigative Medicine, Inc.

🇺🇸

Hawthorne, California, United States

Wade Family Medicine

🇺🇸

Bountiful, Utah, United States

Metabolic Research Institute Inc

🇺🇸

West Palm Beach, Florida, United States

Coastal Metabolic Research Center

🇺🇸

Ventura, California, United States

Medication Management, LLC

🇺🇸

Raleigh, North Carolina, United States

Atlanta Diabetes Associates

🇺🇸

Atlanta, Georgia, United States

Desert Oasis Hlthcr Med Group

🇺🇸

Palm Springs, California, United States

NorCal Endocrinology and Internal Medicine

🇺🇸

San Ramon, California, United States

N.Y. Total Medical Care PC

🇺🇸

Brooklyn, New York, United States

Texas Diabetes & Endocrinology

🇺🇸

Austin, Texas, United States

Clinical Trials Research_Sacramento

🇺🇸

Sacramento, California, United States

Florida Inst For Clin Res

🇺🇸

Orlando, Florida, United States

Central Illinois Diabetes and Clinical Research

🇺🇸

Springfield, Illinois, United States

Diabetes/Lipid Mgmt & Res Ctr

🇺🇸

Huntington Beach, California, United States

Clinical Research of Central Florida_Winter Haven

🇺🇸

Winter Haven, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath